Fibrosis is the concluding pathological outcome and major cause of morbidity and mortality
in a number of common chronic inflammatory, immune-mediated and metabolic diseases …

Interstitial lung diseases (ILDs) comprise a rather heterogeneous group of diseases varying
in pathophysiology, presentation, epidemiology, diagnosis, treatment and prognosis. Even …

Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions
causing significant morbidity and mortality. A multitude of factors beyond the lungs influence …

Adipose tissue has functions beyond its principal functions in energy storage, including
endocrine and immune functions. When faced with a surplus of energy, the functions of …

Research into novel diagnostic techniques and targeted therapeutics in interstitial lung
disease (ILD) is moving the field toward increased precision and improved patient …

Interstitial lung disease (ILD) is a heterogeneous group of disorders with complex and varied
imaging manifestations and prognosis. High-resolution computed tomography (HRCT) is the …

Recent genetic and genomic advancements have elucidated the complex etiology of
idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic interstitial lung diseases …

Interstitial lung diseases (ILDs) encompass a heterogeneous group of lung disorders, each
with its own etiology, clinical presentation, and progression, characterized by inflammation …

Interstitial lung disease (ILD) is a common manifestation of connective tissue disease (CTD),
most often affecting patients with rheumatoid arthritis (RA), systemic sclerosis (SSc) …

Extract Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal fibrotic lung
disease of unknown cause [1]. Other types of pulmonary fibrosis may exhibit a phenotype of …